1. Home
  2. OEC vs VNDA Comparison

OEC vs VNDA Comparison

Compare OEC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$7.15

Market Cap

397.0M

Sector

Industrials

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$5.05

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OEC
VNDA
Founded
1862
2002
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.0M
361.4M
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
OEC
VNDA
Price
$7.15
$5.05
Analyst Decision
Sell
Strong Buy
Analyst Count
4
5
Target Price
$6.56
$14.90
AVG Volume (30 Days)
708.2K
797.2K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,806,700,000.00
$216,105,000.00
Revenue This Year
N/A
$21.35
Revenue Next Year
$2.21
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.72
52 Week Low
$4.35
$4.14
52 Week High
$11.21
$9.91

Technical Indicators

Market Signals
Indicator
OEC
VNDA
Relative Strength Index (RSI) 51.85 29.37
Support Level $6.66 N/A
Resistance Level $7.70 $5.46
Average True Range (ATR) 0.40 0.21
MACD 0.09 -0.06
Stochastic Oscillator 67.69 1.12

Price Performance

Historical Comparison
OEC
VNDA

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: